We offer heartfelt congrats to the winners of the top abstracts at the First International Pediatric Cardio-Oncology Conference. The winners were each presented with a prize from the journal at the conference. The winners, in no particular order, are: Lieke (E.A.M.) Feijen-Allenstein, PhD; Takeshi Tsuda, MD, FACC; Elvira C. van Dalen, MD, PhD; and Christina Yang, MD.
Congratulations to the winners of the top abstracts at the First International Pediatric Cardio-Oncology Conference
Submit to our competition
ICOS, in collaboration with the Thalheimer Center for Cardio-Oncology at the University of Pennsylvania, is delighted to announce a manuscript competition. A panel will judge the published articles and a prize, sponsored by the Thalheimer Center for Cardio-Oncology, will be awarded based on impact and originality.
About the society
Cardio-Oncology is the official journal of the International Cardio-Oncology Society (ICOS). The society brings together cardio-oncologists from around the world with the aim of reducing cardiovascular disease in cancer patients and thereby saving patients' lives. For more information about this important work, please visit the ICOS website.
Members of ICOS currently receive a 25% discount on submissions. The discount should be requested using the ICOS discount code during the submission process. ICOS members unsure of the code for society members, should contact the Publishing Editor.
Aims and scope
The editorial mission of Cardio-Oncology is to advance the science and practice of this emerging field to find a balance between oncologic efficacy and reducing adverse cardiovascular effects through timely publication and dissemination of peer-reviewed research. As an open access, online journal Cardio-Oncology provides a high visibility platform for the publication of original research and expert reviews on the cardiovascular effects of cancer treatment. Read more here.
Articles
-
-
Outcomes of malignancy in adults with congenital heart disease: a single center experience
-
Exercise-induced Brugada pattern and ventricular tachycardia during Capecitabine treatment
-
Case report: challenges in monitoring and treatment of anthracycline induced cardiotoxicity in young adults with osteosarcoma
-
Echocardiographic strategy for early detection of cardiotoxicity of doxorubicin: a prospective observational study
-
Management of atrial fibrillation in patients taking targeted cancer therapies
-
5-FU induced cardiotoxicity: case series and review of the literature
-
Rationale for setting up a cardio-oncology unit: our experience at Mayo Clinic
-
Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
-
Tyrosine kinase inhibitor associated vascular toxicity in chronic myeloid leukemia
Cardiotoxicity of novel anti-cancer therapies
For this Cardio-Oncology article collection, we welcome submissions examining cardiotoxicity caused by chemotherapy, radiotherapy, molecular-targeted agents, and immune-modulating agents. Manuscripts investigating cardiotoxicity related to novel cancer treatments will be highly appreciated. See here for more details.
Indexing announcement
We are pleased to announce Cardio-Oncology has been accepted for indexing in both Scopus and the Emerging Sources Citation Index in 2021. All articles published in Cardio-Oncology are also archived and searchable through PubMed Central. The journal has passed the rigorous evaluation required to be included in these indexes.
Springer Nature Oncology Portfolio
Discover the range of academic oncology titles at Springer Nature here.
Peer Review Taxonomy
This journal is participating in a pilot of NISO/STM's Working Group on Peer Review Taxonomy, to identify and standardize definitions and terminology in peer review practices in order to make the peer review process for articles and journals more transparent. Further information on the pilot is available here.
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: None
We welcome your feedback on this Peer Review Taxonomy Pilot. Please can you take the time to complete this short survey.
Announcing the launch of In Review
Cardio-Oncology, in partnership with Research Square, is now offering In Review. Authors choosing this free optional service will be able to:
- Share their work with fellow researchers to read, comment on, and cite even before publication
- Showcase their work to funders and others with a citable DOI while it is still under review
- Track their manuscript - including seeing when reviewers are invited, and when reports are received
About the Editors
Steven Lipshultz, Editor-in-Chief
Steven E. Lipshultz, MD, FAAP, FAHA is the A. Conger Goodyear Professor and Chair of the Department of Pediatrics at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, The State University of New York; the Chief of Service of Pediatrics at Kaleida Health; the Medical Director of Pediatric Services Business Development at John R. Oishei Children’s Hospital; President of UBMD Pediatrics (University at Buffalo Pediatric Associates, Inc.); and a Consultant in Pediatrics and Cardio-Oncology for the Roswell Park Comprehensive Cancer Center.
Joseph Carver, Deputy Editor
Joseph Carver is the Bernard Fishman Clinical Professor of Medicine at the Abramson Cancer Center of the University of Pennsylvania, the Chief Operating Officer of the Abramson Family Cancer Research Institute of the Abramson Cancer Center of the University of Pennsylvania and the Chief of Staff of the Abramson Cancer Center.
Giorgio Minotti, Deputy Editor
Giorgio Minotti is Professor of Pharmacology, Head of Drug Sciences and Clinical Pharmacology, Chief of Clinical Trial Center, at the University Campus Bio-Medico of Rome. His research interests focus on pharmacokinetics, pharmacodynamics, and clinical correlates of anticancer drugs cardiovascular toxicity.
-
Affiliated with
-
Cardio-Oncology is affiliated with the International Cardio-Oncology Society (ICOS).
-
- Editorial Board
- Manuscript editing services
- Instructions for Editors
- Contact Support for Editors
- Sign up for article alerts and news from this journal
Follow
Annual Journal Metrics
-
Speed
46 days to first decision for all manuscripts (Median)
40 days to first decision for reviewed manuscripts only (Median)Usage
128,227 Downloads (2021)
770 Altmetric mentions (2021)
On the blog
-
Cancer champions – to the local community center… and beyond!
03 February 2022
-
-
Screening for kidney cancer in Leeds
16 April 2021
Institutional membership
Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).